Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tracy Batchelor, MD, MPH
Massachusetts General Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
126 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Yale University
New Haven, Connecticut, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Emory University/winship Cancer Institute
Atlanta, Georgia, United States
- Saint Luke'S Mountain States Tumor Institute
Boise, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute - Fruitland
Fruitland, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute - Meridian
Meridian, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute - Nampa
Nampa, Idaho, United States
- Saint Luke'S Mountain States Tumor Institute-Twin Falls
Twin Falls, Idaho, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Reid Health
Richmond, Indiana, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- Oncology Hematology Care Inc-Crestview
Crestview Hills, Kentucky, United States
- Tulane University Health Sciences Center
New Orleans, Louisiana, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Bronson Battle Creek
Battle Creek, Michigan, United States
- Mercy Health Saint Mary'S
Grand Rapids, Michigan, United States
- Spectrum Health at Butterworth Campus
Grand Rapids, Michigan, United States
- Borgess Medical Center
Kalamazoo, Michigan, United States
- Bronson Methodist Hospital
Kalamazoo, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Mercy Health Mercy Campus
Muskegon, Michigan, United States
- Lakeland Community Hospital
Niles, Michigan, United States
- Spectrum Health Reed City Hospital
Reed City, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2012
- Primary completion
- 10 Dec 2020
- Completion
- 2 May 2027
- Last update posted
- 30 Jan 2026
- Registered enrollment
- 113
- Registry id
- NCT01511562
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.